Bitcoin ETFs draw $137M, pushing October flows positive

U.S.-listed spot Bitcoin ETFs attracted $137 million Wednesday, extending their inflow streak to three days and lifting October’s net flows to $111 million with two sessions left.
U.S.-listed spot Bitcoin exchange-traded funds attracted $137 million on Wednesday, bringing their total inflows over the past three trading days to about $424 million, according to SoSoValue data.
October’s net flows remained negative through Tuesday after investors withdrew nearly $774 million during the final two trading sessions of the previous week. Wednesday’s inflows lifted the monthly total to $111 million, with two trading sessions remaining. Earlier in October, a Bitcoin ETF inflow streak brought in more than $1.08 billion over three sessions before renewed withdrawals reversed those gains.
The inflows came after the Federal Reserve kept its benchmark interest rate at a target range of 3.75% to 4% on Wednesday. Fed Chair Kevin Warsh said inflation remained above the central bank’s 2% target.
“With limited new direction from the Fed, Bitcoin’s near-term performance may depend more heavily on Treasury yields, dollar movements and broader risk sentiment,” Bitget analyst Lewis Huang wrote.
Bitcoin traded at $79,848 at the time of reporting, down about 1% over the previous 24 hours, according to CoinGecko. The Crypto Fear & Greed Index held at 51, a neutral reading, for a second consecutive day.
U.S.-listed Ether exchange-traded funds recorded another $21 million in withdrawals Wednesday, bringing their October net outflows to $1.35 billion. Ether traded at $2,310, down 1.7% over the previous 24 hours.
The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.






